Vicinitas Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $65M
Investors
- 6
About Vicinitas Therapeutics
Based in California, US, and founded in 2022, Vicinitas Therapeutics operates as a biotechnology company that develops small-molecule drugs. The company was founded by Dan Nomura. Vicinitas Therapeutics offers Deubiquitinase Targeting Chimera (DUBTAC), which is a targeted protein stabilization (TPS) platform that is focused on many diseases that are driven by proteins, which include cancer and monogenic diseases. The company's TPS platform provides development based on heterobifunctional small molecules, which contain an OTUB1 recruiter for the deubiquitinase and a ligand that targets proteins.
Who invested in Vicinitas Therapeutics
6 investors across 1 round
See all investors in Vicinitas Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 12, 2022
Amount
$65M
Investors
Questions about Vicinitas Therapeutics
Who invested in Vicinitas Therapeutics?
Vicinitas Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vicinitas Therapeutics raised?
Vicinitas Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vicinitas Therapeutics last raise money?
Vicinitas Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Vicinitas Therapeutics do?
Based in California, US, and founded in 2022, Vicinitas Therapeutics operates as a biotechnology company that develops small-molecule drugs.
Where is Vicinitas Therapeutics headquartered?
Vicinitas Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Vicinitas Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vicinitas Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vicinitas Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.